shares from 2011 to 2023

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary: Elite Pharmaceuticals Inc /Nv/ quarterly/annual Earnings Per Share, Basic history and growth rate from 2011 to 2023.
Elite Pharmaceuticals Inc /Nv/ Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.01 USD/shares, a 200% decline year-over-year.
Elite Pharmaceuticals Inc /Nv/ Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 0 USD/shares, a 100% decline year-over-year.
Elite Pharmaceuticals Inc /Nv/ annual Earnings Per Share, Basic for 2023 was 0.02 USD/shares.
Elite Pharmaceuticals Inc /Nv/ annual Earnings Per Share, Basic for 2022 was 0 USD/shares, a 100% decline from 2021.
Elite Pharmaceuticals Inc /Nv/ annual Earnings Per Share, Basic for 2021 was 0.01 USD/shares, unchanged from 2020.

Earnings Per Share, Basic, Trailing 12 Months (USD/shares)

Earnings Per Share, Basic, Annual (USD/shares)

Earnings Per Share, Basic, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$0.02	+$0.02		Apr 1, 2023	Mar 31, 2024	10-K	2024-07-01
2022	$0	$0	-100%	Apr 1, 2022	Mar 31, 2023	10-K	2024-07-01
2021	$0.01	$0	0%	Apr 1, 2021	Mar 31, 2022	10-K	2023-06-29
2020	$0.01	+$0.01		Apr 1, 2020	Mar 31, 2021	10-K	2022-06-29
2019	$0	+$0.01		Apr 1, 2019	Mar 31, 2020	10-K	2021-06-14
2018	$0	$0		Apr 1, 2018	Mar 31, 2019	10-K	2020-06-30
2017	$0	$0	-100%	Apr 1, 2017	Mar 31, 2018	10-K	2019-06-21
2016	$0.03	+$0.04		Apr 1, 2016	Mar 31, 2017	10-K	2018-06-14
2015	$0	$0	-120%	Apr 1, 2015	Mar 31, 2016	10-K	2018-06-14
2014	$0.05	+$0.26		Apr 1, 2014	Mar 31, 2015	10-K	2017-06-14
2013	$0	$0		Apr 1, 2013	Mar 31, 2014	10-K	2016-06-15
2012	$0	+$0.06		Apr 1, 2012	Mar 31, 2013	10-K	2014-06-30
2011	$0			Apr 1, 2011	Mar 31, 2012	10-K	2013-06-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.